Usha L. Katari

1.1k total citations
11 papers, 850 citations indexed

About

Usha L. Katari is a scholar working on Epidemiology, Oncology and Genetics. According to data from OpenAlex, Usha L. Katari has authored 11 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Oncology and 5 papers in Genetics. Recurrent topics in Usha L. Katari's work include Cytomegalovirus and herpesvirus research (10 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (4 papers). Usha L. Katari is often cited by papers focused on Cytomegalovirus and herpesvirus research (10 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (4 papers). Usha L. Katari collaborates with scholars based in United States and Netherlands. Usha L. Katari's co-authors include Ann M. Leen, Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney, Ulrike Gerdemann, Jacqueline M. Keirnan, Stephen Gottschalk, Juan F. Vera, Αναστασία Παπαδοπούλου and Robert A. Krance and has published in prestigious journals such as Blood, Science Translational Medicine and Molecular Therapy.

In The Last Decade

Usha L. Katari

11 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Usha L. Katari United States	6	585	458	283	272	145	11	850
Anne Christin United States	7	417 0.7×	366 0.8×	306 1.1×	256 0.9×	106 0.7×	11	699
Jacqueline M. Keirnan United States	5	463 0.8×	282 0.6×	213 0.8×	203 0.7×	79 0.5×	6	628
Aisha Hasan United States	14	367 0.6×	226 0.5×	136 0.5×	257 0.9×	112 0.8×	55	696
Simone Kayser Germany	10	394 0.7×	180 0.4×	130 0.5×	264 1.0×	58 0.4×	16	578
Renee Simms Australia	11	322 0.6×	412 0.9×	192 0.7×	136 0.5×	106 0.7×	17	560
John Craddock United States	5	537 0.9×	127 0.3×	230 0.8×	231 0.8×	33 0.2×	10	646
Vincent Pedergnana France	11	148 0.3×	224 0.5×	119 0.4×	351 1.3×	143 1.0×	21	679
Jerill Thorpe United States	12	227 0.4×	164 0.4×	267 0.9×	244 0.9×	120 0.8×	23	740
Jane Burgess Australia	14	239 0.4×	344 0.8×	210 0.7×	162 0.6×	83 0.6×	21	670

Countries citing papers authored by Usha L. Katari

Since Specialization

Citations

This map shows the geographic impact of Usha L. Katari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Usha L. Katari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Usha L. Katari more than expected).

Fields of papers citing papers by Usha L. Katari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Usha L. Katari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Usha L. Katari. The network helps show where Usha L. Katari may publish in the future.

Co-authorship network of co-authors of Usha L. Katari

This figure shows the co-authorship network connecting the top 25 collaborators of Usha L. Katari. A scholar is included among the top collaborators of Usha L. Katari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Usha L. Katari. Usha L. Katari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Tzannou, Ifigenia, Sarah K. Nicholas, Usha L. Katari, et al.. (2015). Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT). Biology of Blood and Marrow Transplantation. 21(2). S170–S170. 2 indexed citations

Παπαδοπούλου, Αναστασία, Ulrike Gerdemann, Usha L. Katari, et al.. (2014). Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT. Science Translational Medicine. 6(242). 242ra83–242ra83. 298 indexed citations

Παπαδοπούλου, Αναστασία, Usha L. Katari, Ulrike Gerdemann, et al.. (2014). Safety and clinical efficacy of rapidly-generated virus-specific T cells with activity against adv, EBV, CMV, HHV6 and BK virus administered after allogeneic hematopoietic stem cell transplant. Cytotherapy. 16(4). S7–S7. 1 indexed citations

Παπαδοπούλου, Αναστασία, Usha L. Katari, Ulrike Gerdemann, et al.. (2014). Safety and Clinical Efficacy of Rapidly-Generated Virus-Specific T Cells with Activity Against Adv, EBV, CMV, HHV6 and BK Virus Administered after Allogeneic Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 20(2). S48–S48. 2 indexed citations

Παπαδοπούλου, Αναστασία, Usha L. Katari, Ulrike Gerdemann, et al.. (2013). Safety and Clinical Efficacy Of Rapidly-Generated Virus-Specific T Cells With Activity Against Adv, EBV, CMV, HHV6 and BK Virus Administered After Allogeneic Hematopoietic Stem Cell Transplant. Blood. 122(21). 148–148. 3 indexed citations

Gerdemann, Ulrike, Usha L. Katari, Αναστασία Παπαδοπούλου, et al.. (2013). Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Molecular Therapy. 21(11). 2113–2121. 171 indexed citations

Gerdemann, Ulrike, Jacqueline M. Keirnan, Usha L. Katari, et al.. (2012). Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections. Molecular Therapy. 20(8). 1622–1632. 188 indexed citations

Gerdemann, Ulrike, Jacqueline M. Keirnan, Usha L. Katari, et al.. (2012). Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation. Blood. 121(1). 207–218. 62 indexed citations

Gerdemann, Ulrike, Usha L. Katari, Jacqueline M. Keirnan, et al.. (2012). Adoptive Transfer of Rapidly-Generated Multivirus-Specific T Cells to Treat Adenovirus, EBV and CMV Infections of Hematopoietic Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 18(2). S219–S219. 1 indexed citations

10.

Gerdemann, Ulrike, Usha L. Katari, Anne Christin, et al.. (2011). Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma. Molecular Therapy. 19(12). 2258–2268. 68 indexed citations

11.

Katari, Usha L., Jacqueline M. Keirnan, Sally E. Hodges, et al.. (2011). Engineered T cells for pancreatic cancer treatment. HPB. 13(9). 643–650. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact